LIWANLI Innovation Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.056x

LIWANLI Innovation Co Ltd cash flow conversion efficiency. Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) has a cash flow conversion efficiency ratio of -0.056x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-41.53 Million ≈ $-1.31 Million USD) by net assets (NT$743.29 Million ≈ $23.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of LIWANLI Innovation Co Ltd (2005–2024)

Cash flow conversion efficiency of LIWANLI Innovation Co Ltd from 2005 to 2024. This chart illustrates how LIWANLI Innovation Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 3054 live share price for real-time trading data and today's change.

LIWANLI Innovation Co Ltd Cash Flow Conversion Ratio Explained

LIWANLI Innovation Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

LIWANLI Innovation Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LIWANLI Innovation Co Ltd ranked by their cash flow conversion efficiency. Also see how much is LIWANLI Innovation Co Ltd worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Doosan Co Ltd
KO:000157
0.010x
DCW Limited
NSE:DCW
0.121x
Flügger group A/S
CO:FLUG-B
0.034x
Fursys
KO:016800
0.002x
Nextronics Engineering
TWO:8147
-0.012x
Can2 Termik AS
IS:CANTE
0.020x
KoMiCo Ltd
KQ:183300
0.078x
Castles Technology Co Ltd
TW:5258
0.095x

Annual Cash Flow Conversion Efficiency for LIWANLI Innovation Co Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of LIWANLI Innovation Co Ltd from 2005 to 2024. Review 3054 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$752.96 Million
≈ $23.72 Million
NT$14.20 Million
≈ $447.44K
0.019x +129.36%
2023-12-31 NT$783.51 Million
≈ $24.68 Million
NT$-50.34 Million
≈ $-1.59 Million
-0.064x -162.66%
2022-12-31 NT$765.36 Million
≈ $24.11 Million
NT$78.48 Million
≈ $2.47 Million
0.103x +250.54%
2021-12-31 NT$897.52 Million
≈ $28.28 Million
NT$-61.13 Million
≈ $-1.93 Million
-0.068x -74.07%
2020-12-31 NT$936.03 Million
≈ $29.49 Million
NT$-36.63 Million
≈ $-1.15 Million
-0.039x +65.38%
2019-12-31 NT$965.79 Million
≈ $30.43 Million
NT$-109.16 Million
≈ $-3.44 Million
-0.113x +5.90%
2018-12-31 NT$1.02 Billion
≈ $32.29 Million
NT$-123.09 Million
≈ $-3.88 Million
-0.120x -291.91%
2017-12-31 NT$1.53 Billion
≈ $48.34 Million
NT$96.03 Million
≈ $3.03 Million
0.063x -15.97%
2016-12-31 NT$1.51 Billion
≈ $47.66 Million
NT$112.68 Million
≈ $3.55 Million
0.074x +138.61%
2015-12-31 NT$1.09 Billion
≈ $34.36 Million
NT$34.04 Million
≈ $1.07 Million
0.031x -91.83%
2014-12-31 NT$1.24 Billion
≈ $39.01 Million
NT$473.04 Million
≈ $14.90 Million
0.382x +686.36%
2013-12-31 NT$1.38 Billion
≈ $43.43 Million
NT$-89.82 Million
≈ $-2.83 Million
-0.065x +52.82%
2012-12-31 NT$753.19 Million
≈ $23.73 Million
NT$-104.02 Million
≈ $-3.28 Million
-0.138x +30.01%
2011-12-31 NT$799.59 Million
≈ $25.19 Million
NT$-157.77 Million
≈ $-4.97 Million
-0.197x -325.30%
2010-12-31 NT$895.33 Million
≈ $28.21 Million
NT$78.41 Million
≈ $2.47 Million
0.088x +9.91%
2009-12-31 NT$1.12 Billion
≈ $35.36 Million
NT$89.43 Million
≈ $2.82 Million
0.080x +4.20%
2008-12-31 NT$666.68 Million
≈ $21.00 Million
NT$50.98 Million
≈ $1.61 Million
0.076x -3.33%
2005-12-31 NT$462.99 Million
≈ $14.59 Million
NT$36.62 Million
≈ $1.15 Million
0.079x --

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$144.33 Million
NT$4.58 Billion TWD
Market Cap Rank
#17590 Global
#901 in Taiwan
Share Price
NT$56.80
Change (1 day)
-0.87%
52-Week Range
NT$22.30 - NT$90.30
All Time High
NT$90.30
About

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for male, female, elderly, and children. Its products include anti-aging desire, pro-active nutrients capsules, black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, algae DHA soft gels, shea butte… Read more